CRBP

Corbus Pharmaceuticals Holdings, Inc.

Biotechnology · Biotechnology

$56.76 sample

+0.92 (+1.65%) 1D

Market cap

$280.4B

Price as of

2026-10-15

Latest filing

8-K · 2026-09-16

Alerts

8

Price$56.76 -0.05% 3M daily closessample

58.4954.33

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 12INSInsider sell: 10% owner
Oct 02INSInsider sell: EVP, Operations
Sep 25INSInsider buy: Chief Executive Officer
Sep 16SEC10-Q filed
Sep 11INSInsider buy: 10% owner
Sep 08SECForm 144 filed
Sep 02INSInsider buy: Chief Executive Officer
Aug 28INSInsider sell: Director

Sign up to see the real CRBP record →

Company facts

SEC EDGAR registration

Name: Corbus Pharmaceuticals Holdings, Inc.
Sector: Biotechnology
Industry: Biotechnology
Smart-money score: -37sample, -100 to +100
Reporting currency: USD

Who is positioning in CRBP

sample

Insiders: 24 insider transactions over 90 days, net selling, $351.3M
Congress: 1 members traded over 90 days
Institutions · 13F: 7 funds hold $5.4B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$11.6B +13.4% y/y

Q4 2024Q3 2026

Inventory$6.8B +10.6% y/y

Q4 2024Q3 2026

Accounts receivable$5.2B +14.5% y/y

Q4 2024Q3 2026

Total debt$14.6B +13.6% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $179.4B -12.9% 3M
Sample peer B: $116.3B +1.3% 3M
Sample peer C: $167.7B +2.4% 3M
Sample peer D: $168.8B -7.1% 3M
Sample peer E: $133.5B -9.1% 3M